𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A PHARMACOKINETIC COMPARISON OF CEFADROXIL AND CEPHALEXIN AFTER ADMINISTRATION OF 250, 500 AND 1000 MG SOLUTION DOSES

✍ Scribed by Rashmi H. Barbhaiya


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
612 KB
Volume
17
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


The pharmacokinetics of cefadroxil and cephalexin were examined following single oral doses of either 250, 500 or 1OOOmg to a total of 36 healthy volunteers. The volunteers were divided into groups of 12 per dose-group and solution doses of cefadroxil or cephalexin were administered after an overnight fast according to a crossover design for the cephalosporins but not for doses. Serial blood and urine samples were collected from each individual and were analyzed for cefadroxil or cephalexin using validated HPLC assays with UV detection. The individual subject plasma concentration-time data for each cephalosporin were analyzed using noncompartmental methods. Profiles for cephalexin in plasma showed sharper and higher peaks than those for cefadroxil. Although values for the peak concentrations (C,A for cefadroxil were lower than that of cephalexin, the levels of cefadroxil in plasma and urine remained above the reported minimum inhibitory concentrations of susceptible organisms for longer period of time than those of cefalexin. The elimination half-life (t,d of cefadroxil (about 2 h) was significantly longer than that of cephalexin (about 1 h). The values for C,, and AUC,, values for both these cephalosporins showed dose-proportional increase, whereas fIl2, renal clearance (CLR) remained independent of dose. These observations confirm that cefadroxil and cephalexin obey linear pharmacokinetics. The CL, of both the cephalosporins were significantly higher than the average glomerular filtration rate at each dose level. The urinary recovery (% Xu) of each cephalosporin, accounted for over 80 per cent of the administered dose, and no significant differences in 7' 0 Xu were observed between the two cephalosporins. These data suggest that the systemic availability of cefadroxil and cephalexin is similar at each dose level.


📜 SIMILAR VOLUMES


The pharmacokinetics of acebvutolol in m
✍ A. A. Gulaid; I. M. James; C. M. Kaye; O. R. W. Lewellen; E. Roberts; M. Sankey; 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract The pharmacokinetics of acebutolol have been studied in eight healthy male volunteers following the oral administration of acebutolol hydrochloride (‘Sectral’, May & Baker) as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d. for 56 days). Following single

Pharmacokinetics and pharmacodynamics of
✍ A. Verhagen; J. T. Ebels; J. H. G. Jonkman; A. A. Dogterom 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 331 KB

The pharmacokinetics and pharmacodynamics of recombinant human growth hormone (rhGH) were studied after a single subcutaneous dose given by jet-injection, and have been compared with the results obtained after conventional needle-injection. Twelve healthy male volunteers completed an open label, ra

Comparison of the absorption of microniz
✍ R. C. Garner; J. V. Garner; S. Gregory; M. Whattam; A. Calam; D. Leong 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

Da¯on 500 1 mg, is a micronized puri®ed ¯avonoid fraction, containing 90% w/w diosmin and 10% w/w of ¯avonoids expressed as hesperidin, used clinically in the treatment of chronic venous insuf®ciency and hemorrhoidal disease. This study was designed to investigate the in¯uence of particle size on th